Bio Sequence

Biological Glossary | What is Coding Sequence (CDS)?

30 October 2023
2 min read

A coding sequence (CDS) is a portion of a gene or an mRNA molecule that specifically codes for a protein. Studying the length, composition, regulation, splicing, structures, and functions of coding regions compared to non-coding regions over different species and time periods can provide a significant amount of important information regarding gene organization and evolution of prokaryotes and eukaryotes. Introns are not coding sequences; nor are the 5' or 3' untranslated regions (or the flanking regions, for that matter - they are not even transcribed into mRNA). This sequence includes a series of codons, which are triplets of nucleotides that specify which amino acids need to be included in the protein during synthesis. Usually, a CDS starts with a start codon (ATG in DNA or AUG in RNA) and ends with a stop codon.

Free registration is available for the Bio biological sequence database: https://bio-patsnap-com.libproxy1.nus.edu.sg. Act now to expedite your sequence search tasks.

图片包含 图示

描述已自动生成

Immatics TCR-T therapy IMA203 is granted RMAT designation by CBER for the treatment of multiple types of cancer
Latest Hotspot
3 min read
Immatics TCR-T therapy IMA203 is granted RMAT designation by CBER for the treatment of multiple types of cancer
30 October 2023
Recently, Immatics announced that its T cell receptor T cell (TCR-T) therapy IMA203 under research has been granted the Regenerative Medicine Advanced Therapy (RMAT) designation by the Center for Biologics Evaluation and Research (CBER) of the U.S. FDA.
Read →
The Evolution of Competitive Landscape Behind the Best Pharmaceutical Agent Tirzepatide in 2023
Bio Sequence
3 min read
The Evolution of Competitive Landscape Behind the Best Pharmaceutical Agent Tirzepatide in 2023
30 October 2023
Exploring the changes occurring within the application structure amongst Tirzepatide's top 10 patent assignees over time delivers insights into the competitive landscape's evolution.
Read →
Exploring Camrelizumab's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
Drug Insights
4 min read
Exploring Camrelizumab's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
31 October 2023
This article summarized the latest R&D progress of Camrelizumab, the Mechanism of Action for Camrelizumab, and the drug target R&D trends for Camrelizumab.
Read →
Decoding Casirivimab: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
Drug Insights
3 min read
Decoding Casirivimab: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
31 October 2023
This article summarized the latest R&D progress of Casirivimab, the Mechanism of Action for Casirivimab, and the drug target R&D trends for Casirivimab.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.